Literature DB >> 12026242

Fluctuation of computed tomographic findings in white matter in Alexander's disease.

Takashi Shiihara1, Mitsuhiro Kato, Tomomi Honma, Shinsuke Ohtaki, Yukio Sawaishi, Kiyoshi Hayasaka.   

Abstract

A Japanese boy developed febrile seizures and gait disturbance at 2 years of age and dysarthria a year later. He had generalized tonic-clonic seizures once or twice a year from the age of 4 years. Brain computed tomography (CT) showed symmetric low-density areas in the white matter of the frontal lobes. However, abnormal CT findings fluctuated occasionally, with no apparent change in clinical manifestations. Clinical evaluation at 9 years of age revealed hyper-reflexia, psychomotor retardation, megalencephaly, and slurred nasal speech. Magnetic resonance imaging showed white matter abnormalities, predominantly in the frontal lobes. He was a heterozygote of the Arg239Cys mutation of the glial fibrillary acidic protein gene and was diagnosed with Alexander's disease. Fluctuation of CT findings in white matter may reflect blood-brain barrier dysfunction in Alexander's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026242     DOI: 10.1177/088307380201700316

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  Seizure-promoting effect of blood-brain barrier disruption.

Authors:  Nicola Marchi; Lilyana Angelov; Thomas Masaryk; Vincent Fazio; Tiziana Granata; Nadia Hernandez; Kerri Hallene; Tammy Diglaw; Linda Franic; Imad Najm; Damir Janigro
Journal:  Epilepsia       Date:  2007-02-23       Impact factor: 5.864

2.  The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells.

Authors:  Tomokatsu Yoshida; Yasuko Tomozawa; Takayo Arisato; Yuji Okamoto; Hirofumi Hirano; Masanori Nakagawa
Journal:  J Hum Genet       Date:  2007-02-22       Impact factor: 3.172

3.  Alexander disease: a leukodystrophy caused by a mutation in GFAP.

Authors:  Anne B Johnson
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.